SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2003
Commission File Number: 0-22286
Taro Pharmaceutical Industries Ltd.
--------------------------------------------------------------------------------
(Translation of registrant's name into English)
Italy House, Euro Park, Yakum 60972, Israel
--------------------------------------------------------------------------------
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F. Form 20-F |X| Form 40-F |_|
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes |_| No |X|
The following is included in this Report on Form 6-K:
1. English translation of the registrant's filings in Hebrew
with the Israeli Registrar of Companies during June 2003
which include:
o Registrant's Annual Report;
o Registrant's Directors Appointment Report;
o Share Issuance Reports.
2
ANNUAL REPORT OF REGISTERED COMPANY
-----------------------------------
--------------------------------------------------------------------------------
Company: Taro Pharmaceutical Industries Limited
--------------------------------------------------------------------------------
No. of Company: 52-002290-6
--------------------------------------------------------------------------------
Address: 14 HaKitor Street, Haifa Bay
--------------------------------------------------------------------------------
Annual Meeting Held on: June 5, 2003
--------------------------------------------------------------------------------
Report Updated until: June 19, 2003
--------------------------------------------------------------------------------
DISTRIBUTION OF SHARES
----------------------
-------------------------------------------- ----------------------- -------------------------------- ------------------------------
NAME OF SHARES SYMBOL OF SHARES NUMBER OF REGISTERED SHARES NUMBER OF ALLOCATED SHARES
-------------------------------------------- ----------------------- -------------------------------- ------------------------------
Founders Shares Founders 2,600 2,600
-------------------------------------------- ----------------------- -------------------------------- ------------------------------
Ordinary Shares Ord. 200,000,000 29,134,536
-------------------------------------------- ----------------------- -------------------------------- ------------------------------
SHAREHOLDERS AND NUMBER OF SHARES THEY OWN
------------------------------------------
---------------------------------- --------------------- --------------------- ----------------- ----------------- -----------------
SHAREHOLDER NAME ID NUMBER ADDRESS SYMBOL OF SHARES NUMBER OF SHARES AMOUNT AS YET
UNPAID FOR SHARES
---------------------------------- --------------------- --------------------- ----------------- ----------------- -----------------
Morley & Co.,Inc. Company Registered 16 Stonewall Lane Founders 2,600
in New-York, USA Mamaroneck, NY 10543
USA
---------------------------------- --------------------- --------------------- ----------------- ----------------- -----------------
Other Shareholders - - - Ordinary 29,134,536
according to the attached list
---------------------------------- --------------------- --------------------- ----------------- ----------------- -----------------
DETAILS OF THE DIRECTORS APPOINTED
----------------------------------
---------------------------- ------------------------- ----------------------------------------------------- -----------------------
DIRECTOR'S NAME ID# ADDRESS DATE OF
APPOINTMENT
---------------------------- ------------------------- ----------------------------------------------------- ------- ------- -------
Michael Friedman 065483450 21 Harevadim St., Jerusalem 93391, ISRAEL 05 06 03
---------------------------- ------------------------- ----------------------------------------------------- ------- ------- -------
Gad Keren 050264035 11 Simha Holtzberg, Kiryat Ono 55426, ISRAEL 05 06 03
---------------------------- ------------------------- ----------------------------------------------------- ------- ------- -------
Heather Douglas CAN VH. 706945 106 The Kings Way, Toronto, ONT M8X 2V1, CANADA 05 06 03
---------------------------- ------------------------- ----------------------------------------------------- ------- ------- -------
Eric Johnston CAN VG. 133978 111 Percy St., Ottowa, ONT K1R 6C5, CANADA 05 06 03
---------------------------- ------------------------- ----------------------------------------------------- ------- ------- -------
Aaron Levitt USA 140398367 233 Beech Court, River Edge, NJ 07661, USA 05 06 03
---------------------------- ------------------------- ----------------------------------------------------- ------- ------- -------
Barrie Levitt USA 140787555 16 Stone Wall Lane, Mamaroneck, NY 10543, USA 05 06 03
---------------------------- ------------------------- ----------------------------------------------------- ------- ------- -------
Tal Levitt USA 141060456 300 Mercer St., #21I, New York, NY 10003, USA 05 06 03
---------------------------- ------------------------- ----------------------------------------------------- ------- ------- -------
Daniel Moros USA 140655646 50 Iselin Terrace, Larchmont, NY 10538, USA 05 06 03
---------------------------- ------------------------- ----------------------------------------------------- ------- ------- -------
Myron Strober USA 151452233 8871 Boatswain Dr., Boyton Beach, FL 33436, USA 05 06 03
---------------------------- ------------------------- ----------------------------------------------------- ------- ------- -------
Irit Hausner 005089877 19 Har HaGilboa, Kiryat Ono 55024, ISRAEL 30 07 98
---------------------------- ------------------------- ----------------------------------------------------- ------- ------- -------
Aryeh Barak 054499645 27 Bnei Moshe, Tel Aviv 62308, ISRAEL 27 08 98
---------------------------- ------------------------- ----------------------------------------------------- ------- ------- -------
3
--------------------------------------------------------------------------------
DETAILS OF DIRECTORS NO LONGER IN OFFICE
--------------------------------------------------------------------------------
---------------- ------------------------ -------------------------------------
NAME ID NUMBER DATE OF TERMINATION
---------------- ------------------------ ------------- ------------- ---------
Eric Hills 48231914 20 10 02
---------------- ------------------------ ------------- ------------- ---------
* DECEASED
MARK [X] IN THE CORRECT PLACE
-----------------------------
[X] No change in details reported regarding foreign directors according to
regulation 16 of the aforesaid regulations
___ Change in details has been reported regarding a foreign director and
relevant required documents have been attached to the Annual Report
according to regulation 16 of the aforesaid regulations.
Fullfillment of Section 171(c) to the law - The directorate has approved the
-------------------------------------------
financial statements; mark [X] if carried out [X]
Fullfillment of Section 173 to the law [mark [X] next to the correct choice]
--------------------------------------
(1) The financial statements were presented at the recent Annual Meeting as
required [X]
(2) If the company is not obligated to hold an Annual Meeting according to
section 61(a) to the law, specify whether the financial statements were
submitted to the shareholders according to section 61(b) to the law ____.
(3) The company is not obligated to submit financial statements at the Annual
Meeting as stated in section 172(g) to the law ____.
Auditor [mark [X] and fill in the details in the correct choice]
-------
(1) The company has an auditor as specified in section 154 of the law [X]. Name
of auditor - KOST FORER & GABAY, address: AMINADAV 3, TEL-AVIV 61575
------------------ --------------------------
(2) The company does not have an auditor ____.
(3) The company is an inactive company, as signified in section 158(a) and it
has been decided at the General Meeting that an auditor will not be
appointed ____.
Company Manager
---------------
If the company has a general manager or head business manager or position
which is responsible for the general management of the company, indicate
name, address and ID number.
Name: SAMUEL RUBINSTEIN Address: 106A DAVID HAMELECH ST., HERZELIYA PITUAH
46661 ID number: 5736034 Office Phone: 09-9711800
Financial Statements
--------------------
A private company for which section 175 of the law applies, will attach
financial statements.
Declaration by Company Directorate according to section 174
-----------------------------------------------------------
[X] I hereby declare in the name of the directorate that the instructions
in section 173(a) to the law have been carried out and that the financial
statements were ____ brought before/ [X] were sent to the shareholders on
30.04.03.
Signature and Declaration:
--------------------------
I hereby declare that the details above are complete and correct and that I
am authorized by the Board of Directors of the Company to sign this Report.
Name Arye Barak
I.D. number 054499645
Signature (-)
4
REPORT OF CHANGE OF DIRECTORS
-----------------------------
---------------------------------- ---------------------------------------------
Company: Taro Pharmaceutical Industries Limited
---------------------------------- ---------------------------------------------
No. of Company: 52-002290-6
---------------------------------- ---------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
DETAILS OF THE DIRECTORS APPOINTED
DATE OF
DIRECTOR'S NAME APPOINTMENT
---------------- CORPORATION ------------------------
PRIVATE FAMILY NAME ID# GENDER ADDRESS YEAR MONTH DAY
----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- -------
Michael Friedman 065483450 Male 21 Harevadim St., Jerusalem 93391, Israel 05 06 03
----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- -------
Gad Keren 050264035 Male 11 Simha Holtzberg, Kiryat Ono 55426, ISRAEL 05 06 03
----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- -------
Heather Douglas CAN VH 706945 Female 106 The Kings Way, Toronto, ONT M8X 2V1, CANADA 05 06 03
----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- -------
Eric Johnston CAN VG 133978 Male 111 Percy St., Ottowa, ONT K1R 6C5, CANADA 05 06 03
----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- -------
Aaron Levitt USA 140398367 Male 233 Beech Court, River Edge, NJ 07661, USA 05 06 03
----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- -------
Barrie Levitt USA 140787555 Male 16 Stone Wall Lane, Mamaroneck, NY 10543, USA 05 06 03
----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- -------
Tal Levitt USA 141060456 Female 300 Mercer St., #21I, New York, NY 10003, USA 05 06 03
----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- -------
Daniel Moros USA 140655646 Male 50 Iselin Terrace, Larchmont, NY 10538, USA 05 06 03
----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- -------
Myron Strober USA 151452233 Male 8871 Boatswain Dr., Boyton Beach, FL 33436, USA 05 06 03
----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- -------
Irit Hausner 005089877 Female 19 Har HaGilboa, Kiryat Ono 55024, ISRAEL 30 7 98
----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- -------
Aryeh Barak 054499645 Male 27 Bnei Moshe, Tel Aviv 62308, ISRAEL 27 8 98
----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- -------
5
--------------------------------------------------------------------------------
DETAILS OF DIRECTOR IN OFFICE ON BEHALF OF A CORPORATION
--------------------------------------------------------------------------------
NAME OF DIRECTOR
--------------------- ----------------------
NAME OF CORPORATION PRIVATE FAMILY ID NUMBER ADDRESS
--------------------- --------------------- ---------------------- -------------------- --------------------
--------------------- --------------------- ---------------------- -------------------- --------------------
--------------------- --------------------- ---------------------- -------------------- --------------------
--------------------------------------------------------------------------------------------------------------------
DETAILS OF DIRECTORS NO LONGER IN OFFICE
--------------------------------------------------------------------------------------------------------------------
------------------ ----------------------------- ----------------------------- -------------------------------------
NAME DATE OF CHANGE
---------------- -------------- ------------- ------------- ---------
FAMILY PRIVATE CORPORATION ID NUMBER YEAR MONTH DAY
---------------- -------------- ----------------------- --------------------- ------------- ------------- ---------
---------------- -------------- ----------------------- --------------------- ------------- ------------- ---------
---------------- -------------- ----------------------- --------------------- ------------- ------------- ---------
---------------- -------------- ----------------------- --------------------- ------------- ------------- ---------
The changes detailed in this form have been |X| / have not been ___ recorded in
the Register of Directors, according to section 224 of the law (check the
correct choice), or give comments __________________.
-----------------------------------------------------
Reported by: MARC COLES
-----------------------------------------------------
I.D. number 015383888
-----------------------------------------------------
Title: VP AND GENERAL COUNSEL
-----------------------------------------------------
Date: JUNE 23, 2003
-----------------------------------------------------
6
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: April 14, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 4,575
For Cash Consideration: 4,575
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D.number: US citizen ID 634460689 Driver Licence DOB07-06-44
Shareholder: Alexander Cossin 0.0001 2,500 11.70
Address: 1 Spruce Drive 500 11.43
Tuxedo NY 10987
U.S.A.
875 21.25
700 59.26
Cash allocation
Amount regarded as paid 2,500 - 11.70NIS; 500 - 11.43NIS;
for each share: 875 - 21.25NIS; 700 - 59.26NIS
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: April 20, 2003
7
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: April 16, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 1,000
For Cash Consideration: 1,000
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: USA Resident
Shareholder: Howard Rutman 0.0001 1,000 17.17
Address: 1199 Park Avenue
New York, NY 10128
U.S.A
Cash allocation
Amount regarded as paid 1,000 - 17.17NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: April 29, 2003
8
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: April 21, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 2,000
For Cash Consideration: 2,000
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Canadian Passport
VM 678149
Shareholder: Rachel Marcks 0.0001 2,000 16.03
Address: 603 Clark Avenue West, Unit #1
Thornhill, ONT L4J 8P9
CANADA
Cash allocation
Amount regarded as paid 2,000 - 16.03NIS for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: April 27, 2003
9
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: April 21, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 1,250
For Cash Consideration: 1,250
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Canadian resident
Shareholder: Teresa Staley 0.0001 1,250 39.93
Address: 825 Norwick Road
Newmarket, ONT L3X 1K8
CANADA
Cash allocation
Amount regarded as paid 1,250 - 39.93NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: April 27, 2003
10
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: April 21, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 25
For Cash Consideration: 25
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Canadian citizen SO484-29604-81108
Shareholder: Godfredo Santiago 0.0001 25 11.40
Address: 516 Ashprior Avenue
Mississauga, ONT L5R 3N1
CANADA
Cash allocation
Amount regarded as paid 25 - 11.40NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: April 27, 2003
11
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: April 21, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 76
For Cash Consideration: 76
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Canadian citizen
R-6889-27424-11203
Shareholder: Gary Rowley 0.0001 50 11.40
Address: 34 Leander Street 26 11.17
Bramdea, ONT L6S 3M6
CANADA
Cash allocation
Amount regarded as paid 50 - 11.40NIS; 26 - 11.17NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: April 27, 2003
12
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: April 21, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 1,000
For Cash Consideration: 1,000
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Drivers License
B2386-42553-70914
Shareholder: Martin Belitz 0.0001 1,000 23.60
Address: 28 Hawleaf Crescent
Willowdale, ONT M2H 3H4
CANADA
Cash allocation
Amount regarded as paid 1,000 - 23.60NIS for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: April 27, 2003
13
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: April 23, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 50
For Cash Consideration: 50
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: US Passport # 954042356
Shareholder: Jacquelyn Castaldo 0.0001 50 11.49
Address: 805 N. Barry Av.
Mamaroneck, NY 10543
U.S.A
Cash allocation
Amount regarded as paid 50 - 11.49NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: May 11, 2003
14
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: April 23, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 74
For Cash Consideration: 74
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Canadian Resident
43-05-179299
Shareholder: Ray Harding 0.0001 74 11.40
Address: 108-703 Edgehill Drive
Barrie, ONT L4N 5A3
CANADA
Cash allocation
Amount regarded as paid 74 - 11.40NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S 140853346
Title: Chief Financial Officer
Date: April 27, 2003
15
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: April 24, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 2,900
For Cash Consideration: 2,900
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Israeli ID # 67467506
Shareholder: Tzvi Tal 0.0001 250 10.86
Address: 25 Golda Meir St., 250 11.14
Haifa 34982
ISRAEL
500 11.36
500 21.13
1,000 54.36
400 58.92
Cash allocation
Amount regarded as paid 250 - 10.86NIS; 250 - 11.14NIS; 500 - 11.36NIS;
for each share: 500 - 21.13NIS; 1,000 - 54.36NIS; 400 - 58.92NIS
Reported by: Kevin Connelly
I.D. number U.S 140853346
Title: Chief Financial Officer
Date: April 27, 2003
16
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: April 28, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 1,000
For Cash Consideration: 1,000
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Israeli ID # 049156532
Shareholder: Hannah Bayer 1,000 67.76
Address: 4 Hatut St.
Ramot Hashavim
ISRAEL
Cash allocation
Amount regarded as paid 1,000 - 67.76NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: April 30, 2003
17
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: April 30, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 25
For Cash Consideration: 25
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Drivers License # 9400-3806-4004
Shareholder: Kevin Murphy 0.0001 25 11.23
Address: 2101 4470 Tucana Court
Mississauga, ONT L5R 3K8
CANADA
Cash allocation
Amount regarded as paid 25 - 11.23NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S 140853346
Title: Chief Financial Officer
Date: May 5, 2003
18
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: May 2, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 50
For Cash Consideration: 50
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D.number: Drivers License # H6015-41076-35315
Shareholder: Josey Hobbs 0.0001 50 11.17
Address: 2563 Proudfoot St.
Mississauga, ONT L5C 2N9
CANADA
Cash allocation
Amount regarded as paid 50 - 11.17NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: May 5, 2003
19
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: April 28, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 25
For Cash Consideration: 25
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Canadian Birth Certificate
ZO 37720
Shareholder: Louanne Powless 0.0001 25 11.38
Address: 34 Albemarle Court
Brampton, ONT L6Z 1R4
CANADA
Cash allocation
Amount regarded as paid 25 - 11.38NIS for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: April 29, 2003
20
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: May 5, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 1,750
For Cash Consideration: 1,750
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Israeli ID # 030590079
Shareholder: Yohanan Dichter 0.0001 150 10.66
Address: 5 Caspri 150 10.93
Haifa 34673
ISRAEL
250 11.16
800 53.37
400 57.85
Cash allocation
Amount regarded as paid 150 - 10.66NIS; 150 - 10.93NIS; 250 -
for each share: 11.16NIS; 800 - 53.37NIS; 400 - 57.85NIS
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: May 14, 2003
21
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: April 25, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 4,000
For Cash Consideration: 4,000
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Drivers License # 06801-32075-55219
Shareholder: Heather Douglas 0.0001 4,000 13.38
Address: 106 The Kingsway
Toronto, ONT M8X 2V1
CANADA
Cash allocation
Amount regarded as paid 4,000 - 13.38NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: May 14, 2003
22
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: April 28, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 25
For Cash Consideration: 25
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Canadian Citizen
Shareholder: Sharon Nicholson 0.0001 25 11.38
Address: 183 Manley Lane
Milton, ONT L9T 5P1
CANADA
Cash allocation
Amount regarded as paid 25 - 11.38NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: April 29, 2003
23
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: May 5, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 400
For Cash Consideration: 400
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: US Passport # 093241410
Shareholder: Walter Jenkins 0.0001 400 57.85
Address: 56 Duke Drive
Carmel, NY 10512
U.S.A
Cash allocation
Amount regarded as paid 400 - 57.85NIS for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: May 14, 2003
24
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: May 7, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 500
For Cash Consideration: 500
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Israeli ID # 056683154
Shareholder: Orna Scheffer 0.0001 125 10.61
Address: 18 Bnei Brit St., 125 10.88
Hod Hasharon 45265
ISRAEL
250 11.10
Cash allocation
Amount regarded as paid 125 - 10.61NIS; 125 - 10.88 NIS;
for each share: 250 - 11.10 NIS
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: May 14, 2003
25
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: May 7, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 750
For Cash Consideration: 750
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: US citizen # 111892362
Shareholder: Kaplana Rao 0.0001 750 11.91
Address: 20 Shafter Avenue
Albertson, NY 11507
U.S.A
Cash allocation
Amount regarded as paid 750 - 11.91NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: May 14, 2003
26
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: May 7, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 800
For Cash Consideration: 800
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: US Citizen
Shareholder: Myron Strober 0.0001 800 105.79
Address: 8871 Boatswain Dr.
Boynton Beach, FL 33436
U.S.A
Cash allocation
Amount regarded as paid 800 - 105.79NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: May 14, 2003
27
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: May 9, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 25
For Cash Consideration: 25
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Canadian ID # 3632306
Shareholder: Nick Spatari 0.0001 25 11.06
Address: 43 Coral Gable Dr.
Toronto, ONT M9M 1N8
CANADA
Cash allocation
Amount regarded as paid 25 - 11.06NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: May 28, 2003
28
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: May 12, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 500
For Cash Consideration: 500
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Israeli ID # 049156532
Shareholder: Hannah Bayer 0.0001 500 66.17
Address: 4 Hatut St.
Ramot Hashavim
ISRAEL
Cash allocation
Amount regarded as paid 500 - 66.17NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: May 14, 2003
29
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: May 22, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 1,800
For Cash Consideration: 1,800
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: US Passport # 092826547
Shareholder: Zvi Rosenthal 0.0001 150 11.10
Address: 98 Walnut Drive 250 11.33
Tenafly, NJ 07670
U.S.A
1,000 21.07
400 58.75
Cash allocation
Amount regarded as paid 150 - 11.10NIS; 250 - 11.33 NIS;
for each share: 1,000 - 21.07 NIS; 400 - 58.75 NIS
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: May 25, 2003
30
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: May 13, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 4,500
For Cash Consideration: 4,500
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Israeli ID # 4823142
Shareholder: Hermona Hills 0.0001 4,500 15.26
Address: 26 Givat Downes
Haifa 34345
ISRAEL
Cash allocation
Amount regarded as paid 4,500 - 15.26NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S. 140853346
Title: Chief Financial Officer
Date: May 14, 2003
31
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Taro Pharmaceutical Industries Ltd.
Date: July 10, 2003 By:/s/ Kevin Connelly
----------------------------------
Kevin Connelly
Senior Vice President and Chief
Financial Officer
32